Product Compliance And Certification For Infant Formula In Uk
UK infant formula is not cleared by one generic ‘certificate’. Market access depends on product category, formulation, manufacturing controls, labelling, notification and, if imported, the route into the target UK territory. Great Britain (GB: England, Scotland and Wales) and Northern Ireland (NI) must be checked separately.
This is a classification and launch-dependency map for food business operators, importers and brand owners, not a substitute for product-specific legal and scientific assessment.
Classify the formula before commissioning tests
Start with actual intended use and full recipe, not the product's retail name. Infant formula is designed to meet infants' nutritional needs on its own in the first months until complementary feeding; follow-on formula is for infants after complementary feeding is introduced. Products presented for dietary management of a disease may need assessment as food for special medical purposes (FSMP), not relabelling as ordinary formula.
- Age and feeding claim: from birth as sole source, or after introduction of complementary feeding?
- Protein source: cow, goat, soya isolate or hydrolysed protein; does the exact source and processing fit the applicable annex?
- Powder or ready-to-feed liquid: which microbiological and process controls apply to this format?
- Special medical or allergy proposition: does it trigger another product category, substantiation or an additional assessment?
- Where sold and where produced: GB, NI, both, or imported from outside the relevant market?
- NI supply route: ordinary NI/EU placing on the market, or eligible GB-to-NI retail movement under NIRMS?
UK product-to-regime decision matrix
| Product situation | Primary legal route | Critical release decision |
|---|---|---|
| Standard infant formula (from birth) | FSG Regulation 609/2013 plus infant-formula rules in Delegated Regulation 2016/127, GB version or EU version in NI | Verify Annex I and ingredient suitability; notify the competent authority of each GB part where the infant formula is placed on the market (Article 12). This notification is not a pre-market licence. Check the applicable NI route separately; validate label and restricted promotion. |
| Standard follow-on formula | Same framework but follow-on composition Annex II and distinct feeding statements | Do not assume universal prior notification: under GB Article 12(2), notification attaches to hydrolysates or other substances outside Annex II; check NI route separately. |
| Formula made with protein hydrolysates | Additional source/process and suitability conditions; GB has a hydrolysate authorisation application route | Check exact authorised/permitted protein specification and required scientific evaluation before investment; notification may also apply. |
| Disease-management or specialist proposition | First determine whether FSMP under Delegated Regulation 2016/128 is the correct category | Do not treat a medical-purpose product as ordinary formula by changing its label; perform separate FSMP review. |
| Dried or ready-to-feed formula | General food hygiene and format-relevant microbiological controls alongside formula-specific rules | For dried infant formula assess Salmonella and Cronobacter criteria; identify controls appropriate to the actual process and shelf life. |
| Eligible GB-to-NI retail shipment under NIRMS | Northern Ireland Retail Movement Scheme (NIRMS): a conditional movement route allowing eligible goods to follow UK public-health and consumer-protection standards; it is not a blanket EU/NI market authorisation. | Check trader registration, eligible goods and NI retail destination, consignment documentation, and individual “Not for EU” marking where required. Resolve any formula-notification question with the competent authority. |
Select GB or Northern Ireland before notifying
In GB, the applicable domestic version of the FSG framework and Delegated Regulation 2016/127 must be read with the relevant nation's enforcement rules. The Department of Health and Social Care coordinates the GB notification forms for England, Wales and Scotland. In NI, relevant EU nutrition rules continue to apply; the UK guidance directs NI notifications to the Food Standards Agency. A GB notification does not by itself prove that a product meets the NI/EU route.
Determine who is the responsible food business operator and where the product is first placed on the market. Use the official infant-formula notification form and submit a model label and any reasonably requested material; for qualifying follow-on formula use the follow-on form. Separately check destination-specific label address, importing and movement rules. Do not assume that submitting a notification is an approval or a certification mark.
The separate NIRMS route matters for eligible retail goods shipped from GB to NI. It can allow compliance with UK public-health and consumer-protection standards instead of the ordinary EU-based route, provided its trader, goods, destination and movement conditions are met. It is not a general exemption for direct imports to NI, exports to the EU or unrestricted UK-wide distribution. Confirm the applicable notification position with the Food Standards Agency before launch; neither an existing GB notification nor a scheme membership should be treated as universal clearance.
For GB, Article 12 requires the operator to notify the relevant authority when the covered formula is placed on the market, using the product label model and any reasonably requested information. As a practical launch control, prepare and submit the required notification before first sales; do not treat submission as a certificate, pre-market approval or a promise of a statutory decision period.
NIRMS does not remove relevant EU animal- and plant-health requirements where these continue to apply to the consignment. In particular, the scheme’s UK public-health and consumer-protection route must not be confused with an exemption from every EU rule.
For commercial imports from the EU into GB, Defra’s Border Target Operating Model (BTOM) guidance expressly lists infant and follow-on formula in the medium-risk category of products of animal origin, irrespective of product type, but separately preserves exemptions for qualifying composite products. Do not infer a universal risk category, IPAFFS requirement, health certificate or inspection route from the word “powder” or “milk” alone: establish the commodity classification, origin, ingredients and any exemption for this exact consignment. The EU-to-GB table does not itself determine imports from non-EU countries or ordinary entry into NI.
Assemble a product-specific evidence file
| Evidence workstream | Documents / tests to assemble | Launch gate |
|---|---|---|
| Classification and formulation | Intended-age statement, complete ingredient/batch recipe, protein origin and processing, nutrients calculated per 100 ml prepared product | Written category and territory decision; Annex I or II gap closed. |
| Ingredient suitability and contaminants | Supplier specifications, ingredient suitability rationale, pesticide/residue controls, stability and compositional verification | All formula-specific and general food-law requirements supported. |
| Manufacturing microbiology | Process flow, HACCP-based hazard controls, monitoring records, product-specific microbiology programme, traceability/recall plan | Relevant Regulation 2073/2005 criteria and shelf-life justification documented. |
| Label and communications | Artwork, mandatory feeding warnings, preparation/storage/disposal directions, allergen information, online pages, promotional plan | Legal and scientific sign-off of pack and advertising together. |
| Operator and supply route | Manufacturer/importer contracts, responsible-operator contact, food-business registration, notification evidence, import commodity assessment | Correct territory authority and, if applicable, border controls resolved. |
| NIRMS retail movement (only if used) | Trader/scheme registration, recipient NI retail premises, product eligibility, movement/consignment records, restricted onward-sale plan and “Not for EU” label artwork | NIRMS eligibility, route, correct individual marking and outstanding notification questions checked before despatch. |
Microbiology scope matters: under Regulation 2073/2005, the Salmonella criterion covers dried infant and dried follow-on formula; the specified Cronobacter criterion targets dried infant formula and dried FSMP for infants under six months. Do not apply the latter automatically to every follow-on powder or ready-to-feed liquid; verify its distinct process and food-safety controls.
Approve label, online listing and promotion together
For infant formula, check the from-birth suitability statement, ‘important notice’ about breastfeeding and independent professional advice, safe-preparation warning, and no nutrition or health claims. Pack imagery must not idealise formula or blur the distinction from follow-on formula. Follow-on formula needs its over-six-month and complementary-feeding statements. Nutrition figures are declared per 100 ml as prepared, not merely per 100 g powder. The applicable law, not marketing preference, determines the exact statements.
Infant formula retail discounts, samples and point-of-sale inducements are restricted; advertisements are limited in their permitted context and content. Screen e-commerce listings, subscription offers, influencer copy and cross-promotion from follow-on products. The time-limited DHA highlighting statement under GB Article 9(3) was available only for formula placed on the market before 22 February 2025: do not reuse it on a new 2026 launch. Do not mistake voluntary quality schemes or laboratory certificates for statutory market authorisation.
For formula moved under NIRMS, review the separate “Not for EU” marking requirements. Defra guidance specifically lists infant or baby powders and formula among shelf-stable composite goods needing individual labels from 1 July 2025; confirm the actual product category and route. That marking is not a substitute for infant-formula statutory information, nor is it a requirement automatically imposed on every formula sold in GB or NI.
Release an infant-formula SKU through six linked gates
- Freeze intended uses, ages, protein source, format and sales territories in a signed classification sheet.
- Map the formula to applicable annexes; commission targeted composition, safety and stability evidence; obtain specialised assessment for hydrolysates/FSMP.
- Verify food-business establishment registration, responsible-party address and the actual manufacturing/traceability controls.
- Complete applicable GB or NI notification/authorisation steps; verify import controls for ingredients and finished formula by composition, origin and route.
- Release only after label, online claims, advertising, documented safety file and logistics are jointly approved.
- For NI, choose ordinary NI/EU placement or an eligible NIRMS retail movement; document eligibility, label marking and any authority notification before shipment.
Reassess formula source, recipe or supply-route changes
A change of protein hydrolysate, ingredient, nutrient level, supplier, plant, shelf life, destination, claims or artwork can affect more than one regime. Re-open the classification, evidence, notification and label assessments before selling the changed SKU. Keep the versions used for the legal check and those actually placed on the market linked by product and batch records.
Official sources and related markets
- UK legislation: infant/follow-on formula
- DHSC: guidance, notification and hydrolysate forms
- DHSC: interpretation and advertising rules
- UK microbiological criteria
- Food information and operator address
- FSA: food business registration
- GOV.UK: NI notification distinction
- NIRMS “Not for EU” formula labelling
- NIRMS scheme and eligibility
- Defra: EU-to-GB infant-formula import risk and composite exemptions
Related market-specific routes:
infant formula in Canada; infant formula in the United States.
Frequently asked questions
Can an importer sell EU-compliant infant formula in GB without further checks?
No automatic conclusion follows from an EU-compliant label. Check the GB version of the compositional rules, the GB notification obligation, responsible-operator details and any border requirements for the actual product.
Must all follow-on formula be notified to DHSC?
No blanket rule should be assumed. GB Article 12(2) particularly covers follow-on formula from protein hydrolysates or containing substances other than those listed in Annex II. Confirm classification and target nations.
Is a hydrolysed-protein formula covered by an ordinary infant-formula notification?
Not necessarily. Its source, processing and scientific suitability need separate assessment; GB provides an application route for authorisation of protein hydrolysates. Notification alone is not proof of this suitability.
Can the pack promote DHA or describe the formula as hypoallergenic?
A new infant-formula launch cannot rely on the expired pre-22 February 2025 DHA-highlight wording. Nutritional and health claims on infant formula are prohibited; allergy or disease propositions require careful category and claims review.
Does a lab certificate replace an official UK approval?
No. Laboratory evidence supports compositional or microbiological compliance but does not replace operator duties, notification when required, lawful claims, or additional hydrolysate authorisation where relevant.
Does one label work unchanged across GB and Northern Ireland?
Do not assume so. Confirm whether GB and applicable EU/NI rules, language, responsible-operator address, nutrition information and marketing restrictions are all satisfied. If the product is moved from GB to NI under NIRMS, also assess eligibility, trader status and the applicable individual “Not for EU” mark; an ordinary NI/EU route has different conditions. Do not assume an identical label is sufficient for all supply chains.